Accuracy in clinically evaluating pigmented lesions.

OBJECTIVE--To determine the ability of three doctors experienced in managing melanocytic lesions to diagnose correctly melanoma, dysplastic naevi, and various benign pigmented lesions. DESIGN--Independent clinical evaluation and histopathological assessment. SETTING--Pigmented lesion clinic, which patients attend without an appointment for early diagnosis of melanoma. PATIENTS--86 Patients with lesions that were judged to be benign by at least one of the three doctors. INTERVENTIONS--The lesions were excised under local anaesthesia and sent for histopathological examination in coded bottles without clinical details. MAIN OUTCOME MEASURE--Comparison of clinical with histopathological diagnosis for each lesion. RESULTS--A total of 120 lesions were evaluated by at least two of the three doctors. The histopathological diagnoses were made by the same pathologist. The overall sensitivity (diagnostic accuracy) for the three doctors for all types of lesion was 50%. Of the 39 dysplastic naevi, only 19 were identified correctly by all observers, and a further 24 banal lesions were wrongly diagnosed as dysplastic by at least one doctor. Particular difficulty was experienced with small (less than 5 mm), flat lesions, which can be banal or potentially malignant. CONCLUSIONS--Critical diagnosis and management decisions concerning pigmented lesions should always be based on a combination of clinical and histopathological assessments and the history of the patient.

[1]  C. J. O'doherty,et al.  Relation between phenotype and banal melanocytic naevi. , 1987, British medical journal.

[2]  E J Lusk,et al.  How well do physicians recognize melanoma and other problem lesions? , 1986, Journal of the American Academy of Dermatology.

[3]  J. Tomich,et al.  Diagnoses of skin disease: dermatologists vs. nondermatologists. , 1985, The Journal of dermatologic surgery and oncology.

[4]  J. Boezeman,et al.  Frequency of moles as a key to melanoma incidence? , 1986, Journal of the American Academy of Dermatology.

[5]  J. Bonerandi,et al.  Dysplastic naevus in non‐familial melanoma. A clinicopathological study of 101 cases , 1988, The British journal of dermatology.

[6]  M. N. Epstein,et al.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.

[7]  V. Siskind,et al.  Common acquired naevi and the risk of malignant melanoma , 1985, International journal of cancer.

[8]  D. Rigel,et al.  The management of patients with dysplastic and congenital nevi. , 1985, Dermatologic clinics.

[9]  F H Rampen,et al.  Referral pattern and accuracy of clinical diagnosis of cutaneous melanoma. , 1988, Acta dermato-venereologica.

[10]  E. Holly,et al.  Number of melanocytic nevi as a major risk factor for malignant melanoma. , 1987, Journal of the American Academy of Dermatology.

[11]  M. Greene,et al.  Acquired precursors of cutaneous malignant melanoma: The familial dysplastic nevus syndrome , 1986 .

[12]  D. Ramsay,et al.  The ability of primary care physicians to recognize the common dermatoses. , 1981, Archives of dermatology.

[13]  W. Clark,et al.  Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma , 1980, Cancer.

[14]  C. Schmoeckel.  How consistent are dermatopathologists in reading early malignant melanomas and lesions "precursor" to them? An international survey. , 1984, The American Journal of dermatopathology.

[15]  S. Becker.  Pitfalls in the diagnosis and treatment of melanoma. , 1954, A.M.A. archives of dermatology and syphilology.

[16]  M. G. Cook,et al.  Melanocytic dysplasia and melanoma , 1985, Histopathology.

[17]  D. Webb,et al.  Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. , 1989, The Journal of physiology.

[18]  R. Griffiths,et al.  Clinical Diagnostic Accuracy in the Management of Primary Stage 1 Cutaneous Malignant Melanoma in a Plastic Surgery Unit , 1984, Bristol medico-chirurgical journal.

[19]  J. Tomich,et al.  Residents’Corner: Diagnoses of Skin Disease: Dermatologists vs. Nondermatologists , 1985 .

[20]  L. Hubener,et al.  Malignant melanoma; a statistical review of clinical and histological diagnoses. , 1956, A.M.A. archives of dermatology.

[21]  M. R. Ewing,et al.  Some observations on the diagnosis of clinically pigmented skin tumours , 1951 .

[22]  A. Kopf,et al.  Diagnostic accuracy in malignant melanoma. , 1975, Archives of dermatology.

[23]  M. Swerdlow.  Nevi; a problem of misdiagnosis. , 1952, American journal of clinical pathology.

[24]  G. Rossoni,et al.  Bronchoconstriction by histamine and bradykinin in guinea pigs: relationship to thromboxane A2 generation and the effect of aspirin. , 1980, Prostaglandins.

[25]  S. Becker.  Diagnosis and treatment of pigmented nevi; consideration of some of the pitfalls. , 1949, Archives of dermatology and syphilology.

[26]  C. J. O'doherty,et al.  Site‐specific melanocytic naevus counts as predictors of whole body naevi , 1988, The British journal of dermatology.

[27]  Briggs Jc,et al.  Clinical Diagnostic Accuracy in the Management of Primary Stage 1 Cutaneous Malignant Melanoma in a Plastic Surgery Unit , 1984, Bristol medico-chirurgical journal.